Caption Management, LLC Kymera Therapeutics, Inc. Put Options Transaction History
Caption Management, LLC
- $9.8 Billion
- Q4 2024
Put Options
1 transactions
Others Institutions Holding KYMR
# of Institutions
186Shares Held
65.5MCall Options Held
49.6KPut Options Held
17K-
Price T Rowe Associates Inc Baltimore, MD6.87MShares$243 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$212 Million2.67% of portfolio
-
Wellington Management Group LLP Boston, MA5.31MShares$187 Million0.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$182 Million7.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.15MShares$182 Million3.02% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $1.93B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...